Experiencia del instituto angel roffo sobre 125 pacientes neutropenicos febriles

Valeria Caseres; Lucila Espinoza; Patricia Bramati; Patricia Costantini; Gabriela Gatica; Silvia Agusto; Ricardo Dos Santos; Viviana Cuartero; Edgardo Pujol; Marta De Pascale; Daniel Santillan; Javier Castillo; Veronica De Toma

Experiencia del instituto angel roffo sobre 125 pacientes neutropenicos febriles

Valeria Caseres, Lucila Espinoza, Patricia Bramati, Patricia Costantini, Gabriela Gatica, Silvia Agusto, Ricardo Dos Santos, Viviana Cuartero, Edgardo Pujol, Marta De Pascale, Daniel Santillan, Javier Castillo, Veronica De Toma

Research output: Contribution to journal › Article › peer-review

Abstract

The aim of the present report is to present an experience with 125 febrile neutropenic patients to examine therapeutic guidelines and to determine the efficacy of treatments, in an attempt to determine the evolution of predictive risk factors. Febrile neutropenia still remains the major cause of morbi-mortality in patiens with chemotherapic-related neutropenia, mainly due to the recent more agressive antineoplastic therapy. We retrospectively studied since March 1993 and propectively between August 1994 and April 1995, 125 patients with neutrophil counts of less than 1.000 and with an axillary temperature of 38° or with signs and symptoms of infectious foci. The results obtained are presented and discussed.

Original language	Spanish
Pages (from-to)	197-200
Number of pages	4
Journal	Prensa Medica Argentina
Volume	83
Issue number	2
State	Published - 1996
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Cite this

@article{0541263ec2f14470a0fc90d243b0d3d4,

title = "Experiencia del instituto angel roffo sobre 125 pacientes neutropenicos febriles",

abstract = "The aim of the present report is to present an experience with 125 febrile neutropenic patients to examine therapeutic guidelines and to determine the efficacy of treatments, in an attempt to determine the evolution of predictive risk factors. Febrile neutropenia still remains the major cause of morbi-mortality in patiens with chemotherapic-related neutropenia, mainly due to the recent more agressive antineoplastic therapy. We retrospectively studied since March 1993 and propectively between August 1994 and April 1995, 125 patients with neutrophil counts of less than 1.000 and with an axillary temperature of 38° or with signs and symptoms of infectious foci. The results obtained are presented and discussed.",

author = "Valeria Caseres and Lucila Espinoza and Patricia Bramati and Patricia Costantini and Gabriela Gatica and Silvia Agusto and {Dos Santos}, Ricardo and Viviana Cuartero and Edgardo Pujol and {De Pascale}, Marta and Daniel Santillan and Javier Castillo and {De Toma}, Veronica",

year = "1996",

language = "Spanish",

volume = "83",

pages = "197--200",

journal = "Prensa Medica Argentina",

issn = "0032-745X",

publisher = "Ediciones Medicas del Sur S.R.L.",

number = "2",

}

TY - JOUR

T1 - Experiencia del instituto angel roffo sobre 125 pacientes neutropenicos febriles

AU - Caseres, Valeria

AU - Espinoza, Lucila

AU - Bramati, Patricia

AU - Costantini, Patricia

AU - Gatica, Gabriela

AU - Agusto, Silvia

AU - Dos Santos, Ricardo

AU - Cuartero, Viviana

AU - Pujol, Edgardo

AU - De Pascale, Marta

AU - Santillan, Daniel

AU - Castillo, Javier

AU - De Toma, Veronica

PY - 1996

Y1 - 1996

N2 - The aim of the present report is to present an experience with 125 febrile neutropenic patients to examine therapeutic guidelines and to determine the efficacy of treatments, in an attempt to determine the evolution of predictive risk factors. Febrile neutropenia still remains the major cause of morbi-mortality in patiens with chemotherapic-related neutropenia, mainly due to the recent more agressive antineoplastic therapy. We retrospectively studied since March 1993 and propectively between August 1994 and April 1995, 125 patients with neutrophil counts of less than 1.000 and with an axillary temperature of 38° or with signs and symptoms of infectious foci. The results obtained are presented and discussed.

AB - The aim of the present report is to present an experience with 125 febrile neutropenic patients to examine therapeutic guidelines and to determine the efficacy of treatments, in an attempt to determine the evolution of predictive risk factors. Febrile neutropenia still remains the major cause of morbi-mortality in patiens with chemotherapic-related neutropenia, mainly due to the recent more agressive antineoplastic therapy. We retrospectively studied since March 1993 and propectively between August 1994 and April 1995, 125 patients with neutrophil counts of less than 1.000 and with an axillary temperature of 38° or with signs and symptoms of infectious foci. The results obtained are presented and discussed.

UR - http://www.scopus.com/inward/record.url?scp=2242482126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2242482126&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:2242482126

SN - 0032-745X

VL - 83

SP - 197

EP - 200

JO - Prensa Medica Argentina

JF - Prensa Medica Argentina

IS - 2

ER -

Experiencia del instituto angel roffo sobre 125 pacientes neutropenicos febriles

Abstract

ASJC Scopus subject areas

Other files and links

Cite this